Acne Vulgaris Treatment Market Continually Growth By Top Leading Players, R&D and research activities, Size, Key Trends, Major Driver, Application, Global Analysis and Forecast to 2026
SEATTLE, March 17, 2021, (PHARMIWEB) — Acne vulgaris is a common skin disease characterized by blackheads, whiteheads, papules, and pustules on the face, neck, back, and chest. Although the condition is more prevalent in adolescent population, it can also affect adults. On the basis of severity of the condition, acne vulgaris can be classified into mild, moderate or severe. Acne vulgaris is caused due to excess oil produced in sebaceous glands under skin, which becomes plugged and inflated. Female patients with polycystic ovarian syndrome and even hormonal disorders such as excess androgen production may suffer from acne. People suffering from acne vulgaris are usually characterized by social withdrawal, low self-esteem, and depression with suicidal tendencies.
Get an exclusive sample copy of business report: https://www.coherentmarketinsights.com/insight/request-sample/1260
The U.S. is expected to be the largest market for acne vulgaris treatment during the forecast period
According to a study published in the British Journal of Dermatology in 2015, 9.4% of the global population was estimated to be affected by acne. Moreover, globally, acne is the eight most prevalent disease. The U.S. is the largest market for acne vulgaris treatment products. According to study by National Institute of Health (NIH), in 2013, over US$ 3 Billion was spent for treating acne vulgaris in the U.S. In 2014, according to American Academy of Dermatology, the number of acne vulgaris patient aged 25 years and above, especially women, is rising significantly. Furthermore, low awareness regarding the factors causing acne is another factor leading to increasing prevalence of acne vulgaris.
The average duration of acne treatment is two years, which allows market players to earn sustainable revenue from acne treatment products. Majority of the population suffering from acne prefer OTC products as the first line therapy. However, some prefer visiting dermatologist for the treatment, owing to ineffective results from OTC products.
Apply Promo Code “CMIFIRST1000” And Get Instant Discount Of USD 1000
Buy-Now this Research Report @ https://bit.ly/2OGV9qT
Acne Vulgaris Treatment Market Taxonomy:
On the basis of product type, the global acne vulgaris treatment market is segmented into:
- Medications
- Benzoyl peroxides
- Retinoids
- Systemic and topical Antibiotics
- Hormonal Agents
- Others (Salicylic Acid, Azelic, Dapsone, and Alternative therapy)
- Devices
- Laser devices
- Heat extraction devices
- Others
Asia Pacific is expected to witness significant growth in the market, owing to increasing population in the age group 15–25 years in India. India also has high glycemic index diet, which is further expected to aid in growth of the market over the forecast period. Key players in the market are focused on developing products and new treatment methods such as cosmetic (laser, chemical peel, and photodynamic therapy) and surgical procedures for the treatment of scarring, resulting from acne. Increasing preference of consumers for alternative ways to treat acne vulgaris such as herbal therapy (tee tree oil), owing to low side effects is another factor expected to aid in growth of the acne vulgaris treatment market. Home-based devices for acne removal such as revive light therapy and neutrogena light therapy are gaining significant traction.
Key players in the acne vulgaris treatment market are focused on adopting collaboration, acquisition, and new product development strategies in order to enhance their product offerings and maintain their position in the market. For instance, in 2017, L’Oréal — a global beauty company — signed an agreement with Valeant Pharmaceuticals International, Inc. to acquire its skin care brands portfolio, which includes anti-acne brand AcneFree at US$1.3 billion. In November 2017 Novan Inc. announced its plans to conduct phase three clinical trial for its new anti-acne molecule. Novan has unique nitric oxide technology, Nitrici, through which a timed release of nitric oxide from chemical entity is possible. This is beneficial as nitric oxide has natural ability to revitalize tissue, eliminate invading microorganisms, prevent clotting, regulate inflammation, and even aid in removing cancer cells. Moreover, in 2017, Valeant Pharmaceuticals International, Inc. signed an agreement with Haitong International Zhonghua Finance Acquisition Fund I, L.P, to sell its Obagi Medical Products business for US$ 190 million in cash. Obagi Medical Products have high presence in acne treatment products market.
Get Sample PDF Brochure with Impact of COVID19: https://www.coherentmarketinsights.com/insight/request-pdf/1260
Key players operating in the global acne vulgaris treatment market include Allergan plc., GlaxoSmithKline plc, Valeant Pharmaceutical International Inc., F.Hoffmann-La Roche AG, Mylan, N.V., Bayer AG, Janssen Pharma Inc., Galderma Inc., Pfizer Inc., and Novan Inc.
Table of Contents
- Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
- Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snippet, By Product Type
- Market Snippet, By Application
- Market Snippet, By End User
- Market Snippet, By Region
- Coherent Opportunity Map (COM)
- Report Description
- Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Impact Analysis
- Key Developments
- PEST Analysis
- Market Dynamics
- Global Acne Vulgaris Treatment – Impact of Coronavirus (Covid-19) Pandemic
- COVID-19 Epidemiology
- Safety Syringes for COIVD-19 Vaccines
- Global Acne Vulgaris Treatment Market, By Product Type, 2016 – 2027, (US$ Mn)
- Global Acne Vulgaris Treatment Market, By Application, 2016 – 2027, (US$ Mn)
- Global Acne Vulgaris Treatment Market, By End User, 2016 – 2027, (US$ Mn)
- Global Acne Vulgaris Treatment Market, By Region, 2016 – 2027, (US$ Mn)
- Introduction
- Market Share Analysis, By Region, 2020 and 2027 (%)
- Y-o-Y Growth Analysis, For Regions, 2017–2027
- North America
- Market Size and Forecast, By Product Type, 2016 – 2027, (US$ Mn)
- Market Size and Forecast, By Application, 2016 – 2027, (US$ Mn)
- Market Size and Forecast, By End User, 2016 – 2027, (US$ Mn)
- Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
- U.S.
- Canada
- Latin America
- Market Size and Forecast, By Product Type, 2016 – 2027, (US$ Mn)
- Market Size and Forecast, By Application, 2016 – 2027, (US$ Mn)
- Market Size and Forecast, By End User, 2016 – 2027, (US$ Mn)
- Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Market Size and Forecast, By Product Type, 2016 – 2027, (US$ Mn)
- Market Size and Forecast, By Application, 2016 – 2027, (US$ Mn)
- Market Size and Forecast, By End User, 2016 – 2027, (US$ Mn)
- Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Market Size and Forecast, By Product Type, 2016 – 2027, (US$ Mn)
- Market Size and Forecast, By Application, 2016 – 2027, (US$ Mn)
- Market Size and Forecast, By End User, 2016 – 2027, (US$ Mn)
- Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Market Size and Forecast, By Product Type, 2016 – 2027, (US$ Mn)
- Market Size and Forecast, By Application, 2016 – 2027, (US$ Mn)
- Market Size and Forecast, By End User, 2016 – 2027, (US$ Mn)
- Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
- GCC
- Israel
- Rest of Middle East
- Africa
- Market Size and Forecast, By Product Type, 2016 – 2027, (US$ Mn)
- Market Size and Forecast, By Application, 2016 – 2027, (US$ Mn)
- Market Size and Forecast, By End User, 2016 – 2027, (US$ Mn)
- Market Size and Forecast, By Country/Region, 2016 – 2027, (US$ Mn)
- South Africa
- Central Africa
- North Africa
- Introduction
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies, to not-for-profit organization, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.
To know more about us, please visit our website – www.coherentmarketinsights.com
Contact:
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837
Editor Details
-
Company:
- CDN Newswire
